메뉴 건너뛰기




Volumn 349, Issue 21, 2003, Pages 1993-2003

Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group

(473)  Friis Møller, Nina a   Sabin, Caroline A a   Weber, Rainer a   d'Arminio Monforte, Antonella a   El Sadr, Wafaa M a   Reiss, Peter a   Thiébaut, Rodolphe a   Morfeldt, Linda a   De Wit, Stephane a   Pradier, Christian a   Calvo, Gonzalo a   Law, Matthew G a   Kirk, Ole a   Phillips, Andrew N a   Lundgren, Jens D a   Bartsch, G a   Dabis, F a   Houyez, F a   Loeliger, E a   Tressler, R a   more..

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 0345064200     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa030218     Document Type: Article
Times cited : (1534)

References (30)
  • 1
    • 0034699898 scopus 로고    scopus 로고
    • Adverse effects of antiretroviral therapy
    • Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-30.
    • (2000) Lancet , vol.356 , pp. 1423-1430
    • Carr, A.1    Cooper, D.A.2
  • 2
    • 0032558803 scopus 로고    scopus 로고
    • Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
    • Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998;12:F167-F173.
    • (1998) AIDS , vol.12
    • Walli, R.1    Herfort, O.2    Michl, G.M.3
  • 3
    • 0034934844 scopus 로고    scopus 로고
    • Dyslipidaemia in HIV-infected patients: Association with adherence to potent antiretroviral therapy
    • Vergis EN, Paterson DL, Wagener MM, Swindells S, Singh N. Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy. Int J STD AIDS 2001;12:463-8.
    • (2001) Int J STD AIDS , vol.12 , pp. 463-468
    • Vergis, E.N.1    Paterson, D.L.2    Wagener, M.M.3    Swindells, S.4    Singh, N.5
  • 4
    • 0036151417 scopus 로고    scopus 로고
    • Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors
    • Galli M, Ridolfo AL, Adorni F, et al. Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2002;29:21-31.
    • (2002) J Acquir Immune Defic Syndr , vol.29 , pp. 21-31
    • Galli, M.1    Ridolfo, A.L.2    Adorni, F.3
  • 5
    • 0038386036 scopus 로고    scopus 로고
    • Cardiovascular risk factors in HIV patients - Association with antiretroviral therapy: Results from the DAD study
    • Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular risk factors in HIV patients - association with antiretroviral therapy: results from the DAD study. AIDS 2003;17: 1179-93.
    • (2003) AIDS , vol.17 , pp. 1179-1193
    • Friis-Møller, N.1    Weber, R.2    Reiss, P.3
  • 6
    • 0033583977 scopus 로고    scopus 로고
    • Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
    • Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.
    • (1999) Lancet , vol.353 , pp. 2093-2099
    • Carr, A.1    Samaras, K.2    Thorisdottir, A.3    Kaufmann, G.R.4    Chisholm, D.J.5    Cooper, D.A.6
  • 7
    • 17144463863 scopus 로고    scopus 로고
    • Severe premature coronary artery disease with protease inhibitors
    • Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328.
    • (1998) Lancet , vol.351 , pp. 1328
    • Henry, K.1    Melroe, H.2    Huebsch, J.3
  • 8
    • 0032564571 scopus 로고    scopus 로고
    • Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir
    • Karmochkine M, Raguin G. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir. AIDS 1998;12:2499.
    • (1998) AIDS , vol.12 , pp. 2499
    • Karmochkine, M.1    Raguin, G.2
  • 9
    • 0033527333 scopus 로고    scopus 로고
    • Myocardial infarction in HIV-infected men receiving protease inhibitors
    • Flynn TE, Bricker LA. Myocardial infarction in HIV-infected men receiving protease inhibitors. Ann Intern Med 1999;131:548.
    • (1999) Ann Intern Med , vol.131 , pp. 548
    • Flynn, T.E.1    Bricker, L.A.2
  • 10
    • 0032572191 scopus 로고    scopus 로고
    • Vascular complications associated with use of HIV protease inhibitors
    • Vittecoq D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998;351:1959.
    • (1998) Lancet , vol.351 , pp. 1959
    • Vittecoq, D.1    Escaut, L.2    Monsuez, J.J.3
  • 11
    • 0038466343 scopus 로고    scopus 로고
    • Coronary artery disease in HIV infected patients
    • Escaut L, Monsuez JJ, Chironi G, et al. Coronary artery disease in HIV infected patients. Intensive Care Med 2003;29:969-73.
    • (2003) Intensive Care Med , vol.29 , pp. 969-973
    • Escaut, L.1    Monsuez, J.J.2    Chironi, G.3
  • 12
    • 0242311025 scopus 로고    scopus 로고
    • Increasing incidence of cardiovascular disease in HIV-infected persons in care
    • Boston, February 10-14. abstract
    • Moore RD, Keruly JC, Lucas G. Increasing incidence of cardiovascular disease in HIV-infected persons in care. Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, February 10-14, 2003:132. abstract.
    • (2003) 10th Conference on Retroviruses and Opportunistic Infections , pp. 132
    • Moore, R.D.1    Keruly, J.C.2    Lucas, G.3
  • 13
    • 0345533343 scopus 로고    scopus 로고
    • Coronary heart disease in HIV-infected individuals: Associations with antiretroviral therapy
    • abstract
    • Currier J, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals: associations with antiretroviral therapy. Antiviral Ther 2002;7:L37. abstract.
    • (2002) Antiviral Ther , vol.7
    • Currier, J.1    Taylor, A.2    Boyd, F.3
  • 14
    • 0037714994 scopus 로고    scopus 로고
    • Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: An analysis of four different protease inhibitors
    • Coplan PM, Nikas A, Japour A, et al. Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors. AIDS Res Hum Retroviruses 2003;19:449-55.
    • (2003) AIDS Res Hum Retroviruses , vol.19 , pp. 449-455
    • Coplan, P.M.1    Nikas, A.2    Japour, A.3
  • 15
    • 0037456351 scopus 로고    scopus 로고
    • Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection
    • Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-10.
    • (2003) N Engl J Med , vol.348 , pp. 702-710
    • Bozzette, S.A.1    Ake, C.F.2    Tam, H.K.3    Chang, S.W.4    Louis, T.A.5
  • 16
    • 0037103407 scopus 로고    scopus 로고
    • Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
    • Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002;30:471-7.
    • (2002) J Acquir Immune Defic Syndr , vol.30 , pp. 471-477
    • Klein, D.1    Hurley, L.B.2    Quesenberry Jr., C.P.3    Sidney, S.4
  • 17
    • 0037202854 scopus 로고    scopus 로고
    • Protease inhibitors and cardiovascular outcomes in patients with HIV-1
    • Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002;360:1747-8.
    • (2002) Lancet , vol.360 , pp. 1747-1748
    • Holmberg, S.D.1    Moorman, A.C.2    Williamson, J.M.3
  • 18
    • 0003282339 scopus 로고    scopus 로고
    • Impact of treatment with protease inhibitor (PI) on myocardial infarction (MI) occurrence in HIV-infected men
    • Program and abstracts, Chicago, February 4-8. abstract
    • Mary-Krause M, Cotte L, Partisani M, Simon A, Costagliola D. Impact of treatment with protease inhibitor (PI) on myocardial infarction (MI) occurrence in HIV-infected men. In: Program and abstracts of the Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, February 4-8, 2001:657. abstract.
    • (2001) Eighth Conference on Retroviruses and Opportunistic Infections , pp. 657
    • Mary-Krause, M.1    Cotte, L.2    Partisani, M.3    Simon, A.4    Costagliola, D.5
  • 19
    • 0242279392 scopus 로고    scopus 로고
    • Hospitalizations for coronary heart disease and myocardial infarction among men with HIV-1 infection: Additional follow-up
    • Boston, February 10-14. abstract
    • Klein D, Hurley L. Hospitalizations for coronary heart disease and myocardial infarction among men with HIV-1 infection: additional follow-up. Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, February 10-14, 2003:747. abstract.
    • (2003) 10th Conference on Retroviruses and Opportunistic Infections , pp. 747
    • Klein, D.1    Hurley, L.2
  • 20
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 21
    • 0037333717 scopus 로고    scopus 로고
    • An objective case definition of lipodystrophy in HIV-infected adults: A case-control study
    • Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003;361:726-35.
    • (2003) Lancet , vol.361 , pp. 726-735
    • Carr, A.1    Emery, S.2    Law, M.3    Puls, R.4    Lundgren, J.D.5    Powderly, W.G.6
  • 22
    • 0027122957 scopus 로고
    • 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
    • 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41(RR-17):1-19.
    • (1992) MMWR Recomm Rep , vol.41 , Issue.RR-17 , pp. 1-1719
  • 23
    • 0028298802 scopus 로고
    • Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
    • Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
    • (1994) Circulation , vol.90 , pp. 583-612
    • Tunstall-Pedoe, H.1    Kuulasmaa, K.2    Amouyel, P.3    Arveiler, D.4    Rajakangas, A.M.5    Pajak, A.6
  • 25
    • 84872888962 scopus 로고    scopus 로고
    • WHO MONICA Project. MONICA manual, part IV: event registration. (Accessed September 19, 2003, at http:/www.ktl.fi/publications/monica/manual/part4/iv-1. htm.)
    • MONICA Manual, Part IV: Event Registration
  • 26
    • 0032576426 scopus 로고    scopus 로고
    • Changing patterns of mortality across Europe in patients infected with HIV-1
    • Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998;352:1725-30.
    • (1998) Lancet , vol.352 , pp. 1725-1730
    • Mocroft, A.1    Vella, S.2    Benfield, T.L.3
  • 27
    • 0037264619 scopus 로고    scopus 로고
    • Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study
    • Law M, Friis-Møller N, Weber R, et al. Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study. HIV Med 2003;4:1-10.
    • (2003) HIV Med , vol.4 , pp. 1-10
    • Law, M.1    Friis-Møller, N.2    Weber, R.3
  • 28
    • 0032482329 scopus 로고    scopus 로고
    • Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: The Bogalusa Heart Study
    • Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 1998;338:1650-6.
    • (1998) N Engl J Med , vol.338 , pp. 1650-1656
    • Berenson, G.S.1    Srinivasan, S.R.2    Bao, W.3    Newman III, W.P.4    Tracy, R.E.5    Wattigney, W.A.6
  • 29
    • 0034716468 scopus 로고    scopus 로고
    • Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
    • Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
    • (2000) Lancet , vol.355 , pp. 675-687
    • Kuulasmaa, K.1    Tunstall-Pedoe, H.2    Dobson, A.3
  • 30
    • 0032499462 scopus 로고    scopus 로고
    • Myth and paradox of coronary risk and the menopause
    • Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998;351:1425-7.
    • (1998) Lancet , vol.351 , pp. 1425-1427
    • Tunstall-Pedoe, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.